Unit 2 Pathophysiology - Chapter 9 Alterations in Immunity and Inflammation Flashcards
autoimmunity
immune response misdirected against host’s own tissues
alloimmunity
directed responses against beneficial foreign tissues, such as transfusions or transplants
allergy
exaggerated response against environmental antigen
Hypersensitivity reaction times
immediate (develop within mins to few hrs) or delayed (developing within several hours or days)
Anaphylaxis
most rapid immediate hypersensitivity rxn, it occurs within minutes of reexposure to the antigen and l/t cardiovascular shock
blood pressure drops suddenly and the airways narrow, blocking breathing. Signs and symptoms include a rapid, weak pulse; a skin rash; and nausea and vomiting.
Allergens
antigens causing allergic responses
Type I (IgE-mediated) hypersensitivity reaction – simple version
immediate hypersensitivity; mediated by antigen specific IgE and products of tissue mast cells
IgE (attached to immune cells in blood) - antibodies produced d/t allergen => IgE antibody bind to Fc receptors on mast cells and then those bounded IgE antibodies are cross-linked by antigens that bind to the Fab portions of IgE
- causes mast cell degranulation and release of histamine and others
Histamine receptors
H1 receptor
* contracts bronchial smoooth muscles => constriction
* increases vascular permeability => edema + vasodilation
* increase blood flow to affect area
Histamine w/ h2 receptor
* increased gastric acid secretion
* decrease of histamine relased from mast cells + basophils (immune cells or WBC with granules that release during allergic rxn or asthma)
Histamines and eosinophils?
Histamine enhances chemotaxis of eosinophils (parasitic infections, allergy, or cancer) into sites of type 1 allergic reactions
Atopic individuals
produce more Ige and more Fc receptors for IgE on their mast cells
Type II (tissue-specific) hypersensitivity reaction
Specific cell or tissue being targeted by an immune response; tissue-specific antigens (e.g platelets have groups of antigens that are found on no other cells of the body OR environmental antigens bind to specific plasma membranes of specific cells (erythrocytes and platelets)
mediated by IgG (blood and tissue) or IgM (mostly in blood) antibodies
5 possible mechanisms:
* complement-mediated lysis => 1st antibody IgG or IgM => complement cascade => membrane attak complex (c5-9) created to damage and lyse cell (e.g autoimmune hemolytic anemia or alloimmune rxn to ABO-mismatched transfused blood cells)
* opsonization and phagocytosis (IgG and C3b of complement system bind to receptors of macrophage => l/t phagocytosis of target cell)
* neutrophil-mediated tissue damage (antibody and complement may attract neutrophils => 1st endothelial cells with deposited antigens on its surface may bind to antibody => l/t complement cascade producing c3a and c5a [chemotactic for neutrophils] and deposition of complement component c3b => neutrophils bind to tissues w/ Fc receptor (contribute to the protective functions of the immune system, by binding to antibodies that are attached to infected cells or invading pathogens) or for c3b to attempt to phagocytose the tissue => neutrophil granules and toxic o2 products will damage cell, but cannot complete phagocytosis d/t large tissue
* antibody-dependent cell-mediated cytotoxicity => NK natural killer cells [not antigen specific], instead antibody on target cell recognized by Fc receptors on NK cells => l/t released substances to destroy cell
* modulation of cellular function => cause cell to malfunction rather than destroy cell => antibody reacts to target cell receptors by preventing interactions with normal ligands and replacing ligand and simulating receptor or destroying receptor (e.g Graves disease - autoantibody binds, instead of TSH, to receptors for TSH l/t increased thyorixine b/c anti-TSH receptor antibody is not controlled by pituitary (if increased thyroxine detected then TSH decreases and in this case it is but the antibody continues to be present)
Type III (immune complex-mediated)
caused by formation of immune complexes deposited in target tissues => activate complement cascade => generate chemotatic fragments that attract neutrophils into inflammatory sites => releasing lysosomal enzymes that result in tissue damage
What can intermediate-sized complexes do?
severe pathologic consequences
Immune complex disease can be a systemic reaction or localized?
Yes
* serum sickness (systemic) - characterized by skin rash, joint stiffness, joint pain, facial and extremity swelling, and fever. Sometimes vomiting or respiratory distress happen. It may be mistaken for anaphylaxis.
* arthrus reaction (localized) - a dermal inflammatory reaction due to local IC (circulating immune complexes) formation after repeated subcutaneous or intradermal injections of foreign antigens.
Type IV (cell mediated) hypersentivity reactions
Cell mediated
delayed hypersensitivity; caused by either cytotoxic T lymphocytes (Tc cells) or lymphokine-producing Th1 cells (substance produced by lymphocytes, such as interferon, that acts upon other cells of the immune system)
examples: graft rejection and allergic reactions resulting from contact w/ substances such as poison ivy and metals (versus type 1 where it is more generalized due to a particular food while type IV is localized in terms of lesion presentation)
Typical allergens
pollen, mold, fungi, certain foods (milk, eggs, fish, peanuts), animals, certain drugs, cigarette smoke and house dust
Clinical manifestations of allergic reactions
confined to areas of initial intake or contact w/ allergen